The customer acknowledges that there are risks in the handling, use, and distribution of these products, and certifies that it has the proper equipment, facilities, and personnel for managing those risks
While the neuroprotective effect in preclinical studies is clear, clinical findings have so far failed to demonstrate an arresting effect on cognitive
In fact, 1 year after discontinuing the use of GLP-1 drugs, patients regain two-thirds of their prior weight loss
"Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial." The Lancet Diabetes & Endocrinology
This practice has been shown to aid GLP-1 stimulation and insulin sensitivity by aligning food intake with circadian rhythms
The BPC-157 dose warrants specific context: 500mcg (0.5mg) per serving is the disclosed oral dose